Skip to main content
Caplight Logo









Hyro

Hyro

Private
New York City, New YorkHealthcare & Life Scienceshttps://hyro.ai

Last Round

Strategic

Oct 21, 2025

Est. Valuation

$244.5M

Total Funding Raised

$140M

Company Overview

Hyro operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Strategic round in October 2025.

Hyro is a healthcare technology company that provides an AI-powered Adaptive Communications Platform to automate patient interactions across voice, chat, and SMS channels.

Sector

Healthcare & Life Sciences

Verticals

NLP & Conversational AI, Patient Engagement, Medical AI, Workflow Automation, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Hyro Comparables

Compare Hyro with similar companies based on industry and business-model similarity.

Hyro comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Notable
87%
Assort Health
85%
Orbita
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Hyro Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicOct 21, 2025
Growth EquityOct 21, 2025
Series B ExtensionDec 10, 2024
Series BMay 31, 2023
Series AMay 25, 2021
Seed
Jul 1, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Rom Cohen

Co-founder And CIO

Founding Team

Israel Krush

CEO & Co-Founder

Founding Team

Nitzan Bar

Chief Technology Officer

Executive Team

Maor Iger

Chief Financial Officer

Executive Team

For institutional investors. Book with your work email.

Hyro Investors

Notable investors and investment history

Hyro investors
InvestorRounds
Define VenturesStrategic, Growth Equity
Spero VenturesSeries B, Series A
Liberty Mutual Strategic VenturesSeries B
Entrepreneurs Roundtable AcceleratorSeries A, Seed
Macquarie GroupSeries B
Hanaco VCSeries A, Seed, Series B
K20 FundSeries B
Book a demo to see all 18 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2026

    Hackensack Meridian Health disclosed as a client.

  • May 1, 2026

    Baptist Health disclosed as a new client.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • recognized_asOct 21, 2026

    Inc. recognizes Hyro on its 2026 Inc. 5000 list of the nation's fastest-growing private companies, alongside recognition on its 2026 Best Workplaces list in the Healthcare & Medical category.

  • recognized_asAug 11, 2026

    Hyro is ranked No. 677 by Inc. on the 2026 Inc. 5000 List, which recognizes America's fastest-growing private companies, in New York on Aug 11th '26.

Book a demo to see all news

For institutional investors. Book with your work email.

Hyro Filings

Explore SEC and related filing metadata, where available.

Hyro filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Hyro's valuation, stock price, and market status.

Is Hyro a public or private company?

Hyro is a private company.

What is the current stock price of Hyro?

Hyro is a private company, so its shares have no public market price. Caplight tracks Hyro's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Hyro worth (valuation)?

Hyro's valuation is estimated at $244.5M based on funding round data.

Can I buy Hyro stock?

Hyro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Hyro's last funding round?

Hyro's most recent funding round was Strategic on October 21, 2025.

Who are the main investors in Hyro?

Key investors in Hyro include Spero Ventures, Macquarie Group, Macquarie Bank Europe, Macquarie Capital, Healthier Capital.

Will Hyro IPO soon?

No public IPO plans have been announced for Hyro.

How can I track Hyro secondary market activity?

Caplight tracks bids, offers, and trades in Hyro's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range166
Year Founded2018
Last FundingOct 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?